论文部分内容阅读
近十余年来,对于前列腺素(Prostaglandin,简称PG)的研究迅速发展,已知有许多生理及病理反应与PG的释放有密切关系。因而作为PG的合成抑制剂阿斯匹林及消炎痛等的应用也愈来愈广泛。但为了达到治疗的目的,既往使用阿斯匹林及消炎痛的口服量较大,常出现一些副作用,使临床应用受到了一定的限制。我们将纯消炎痛粉剂制成眼用膜剂新剂型,放入结膜囊内,经动物试验及临床初步观察,认为效果较为明显,方法也较简便,目前尚未见有报道,故介绍如下:
In recent ten years, prostaglandin (Prostaglandin, PG for short) rapid development of the known, there are many physiological and pathological reactions and release of PG are closely related. Therefore, as PG synthesis inhibitors aspirin and indomethacin and other applications are also more and more widely. However, in order to achieve the purpose of treatment, aspirin and indomethacin in the past with a large oral dose, often some side effects, the clinical application of certain restrictions. We will be made of pure anti-inflammatory powder ophthalmic formulations of new formulations, into the conjunctival sac, animal experiments and clinical preliminary observation, that the effect is more obvious, the method is also relatively simple, there are no reports, it is introduced as follows: